Health

Frost & Sullivan Recognizes DrFirst for Solutions Providing Secure Communication, Collaboration, and Real-Time Access to Patient Information at the Point of Care

DrFirst wins Digital Health Data Industry New Product Innovation Award for its suite of products that improve healthcare providers' clinical view of patients' medical information and drug regimens SANTA CLARA, California, July 9, 2020 /PRNewswire/ -- Providers across multiple care settings requi...

2020-07-09 21:00 1574

New Report Reviews Global Hospital Practices in Pandemic Flu Response

SINGAPORE, July 9, 2020 /PRNewswire/ -- Eden Strategy Institute today unveiled a global review of hospital practices in dealing with flu pandemic, drawing novel and interesting insights from the current COVID-19 pandemic as well as from previous pandemics such as SARS, H1N1, and Ebola. This rese...

2020-07-09 17:19 1829

WuXi AppTec to Launch a Special Webinar on Collaborations that Transform on July 16 | Advances in Rare Diseases: Hemophilia

SHANGHAI and SAN DIEGO, July 9, 2020 /PRNewswire/ -- WuXi AppTec is pleased to announce that they are about to launch the second session of the webinar series "Collaborations That Transform," highlighting the impact of partnerships in bringing effective therapies to patients. This complimentary w...

2020-07-09 16:32 1434

AGC Biologics Collaborates with Molecular Partners AG to Develop Anti-COVID-19 DARPin® Program

SEATTLE, July 9, 2020 /PRNewswire/ -- Global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO)AGC Biologics is partnering with clinical-stage biotech companyMolecular Partners AG to develop a new class of custom-built protein therapeutics known as DARPin®. AGC Biologics...

2020-07-09 13:00 2433

Men Are Discreet About Their Negative Body Confidence and Self-perception, Observes Dr Ivan Puah, Medical Director Of Amaris B. Clinic

SINGAPORE, July 9, 2020 /PRNewswire/ -- Dr Ivan Puah, Medical Director of Amaris B. Clinic, is seeing an increasing number of males seeking treatment for gynecomastia and surgical reduction of localised fat in recent years due to body dissatisfaction. Men, just like women, do care about their ...

2020-07-09 12:30 3077

Innovent Announces First Patient Dosed in a Phase 1b Clinical Trial of Sintilimab plus Surufatinib in Advanced Malignancies in China

SUZHOU, China, July 9, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major diseases, today anno...

2020-07-09 08:00 11981

Paige Applauded by Frost & Sullivan for its Leading AI-based Computational Pathology Offering that Enables Fast and Accurate Cancer Diagnoses

Paige leveraged the world's largest dataset in pathology to develop an unparalleled computation pathology offering SANTA CLARA, California, July 8, 2020 /PRNewswire/ -- Based on its recent analysis of the North American AI-based digital pathology market, Frost & Sullivan recognizesPaige with the...

2020-07-08 23:40 1668

Asieris Received China NMPA's Approval to Start a Global Phase III Clinical Trial for APL-1702 to Treat Cervical Precancerous Lesions (HSIL)

SHANGHAI, July 8, 2020 /PRNewswire/ -- Asieris Pharmaceuticals (Asieris), a China-based biotech company with global aspirations to discover, develop and commercialize innovative drugs for the treatment of genitourinary tumors and related diseases, announced today it has received Clinical Trial Ap...

2020-07-08 22:00 1237

Frost & Sullivan Honors Leading Organizations in Asia-Pacific in an Inaugural Virtual Ceremony for the 2020 Asia-Pacific Best Practices Awards

SINGAPORE, July 8, 2020 /PRNewswire/ -- Frost & Sullivan honored Asia-Pacific's leading companies at the18th annual Asia-Pacific Best Practices Awards on 8 July in an inaugural virtual awards ceremony. A total of15 awards were presented to organizations for elevating performance benchmarks and fo...

2020-07-08 19:03 1756

Lipidor Signs Agreement With CRO for Implementation of Phase III Clinical Study of Drug Candidate AKP-02 Against Psoriasis

STOCKHOLM, July 8, 2020 /PRNewswire/ -- Lipidor AB (Nasdaq First North: LIPI) today announced an agreement with Cadila Pharmaceuticals, a leading Indian pharmaceutical company with extensive CRO capacity, to conduct a Phase III study for Lipidor's drug candidate AKP-02. The study is expected to c...

2020-07-08 14:57 1587

Sun Life Hong Kong Boosts Diabetes Awareness

HONG KONG, July 8, 2020 /PRNewswire/ -- Today marks the official release of Is Something Wrong with Granny?!, a children's picture book published by Diabetes Hongkong and sponsored by Sun Life Hong Kong Limited ("the Company" or "Sun Life Hong Kong"). Little Kwong, the protagonist of the story, i...

2020-07-08 14:54 2813

Rapidly Changing Behaviours In 2020 Are Accelerating Consumer Embrace of Digital, Health, and Sustainability Trends, Says PwC

NEW YORK, July 8, 2020 /PRNewswire/ --  * 45% of global consumers say healthcare is one of the top three reasons for living in a city * 69% of global consumers are more focused on mental health and well being * 43% of global consumer expect businesses to be accountable for their environment...

2020-07-08 12:00 2991

Turning Point Therapeutics and Zai Lab Announce Exclusive License Agreement for Repotrectinib in Greater China

SHANGHAI, July 8, 2020 /PRNewswire/ -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, and Zai Lab (NASDAQ: ZLAB), an innovative commercial-stage biopharmaceutical company, today announced an...

2020-07-08 11:37 2393

Evive Biotech meets primary and secondary endpoints in global Phase III clinical trial for their novel chemotherapy-induced neutropenia treatment

* Safety and efficacy endpoints met successfully in pivotal trial for F-627 (efbemalenograstim alfa), a novel long-acting G-CSF * Key milestone and validation for Evive's novel biologic development capability and technology platform * Key component of the asset's BLA submission to receive re...

2020-07-08 09:00 1736

ILIAS Biologics Granted Key Patent for Exosome-based Drug Delivery System in the United States

DAEJEON, South Korea, July 7, 2020 /PRNewswire/ -- ILIAS Biologics Inc. (the "Company" or "ILIAS"), a global leader in exosome-based therapeutics, announced today that the Company has been granted a key exosome engineering patent by the United States Patent and Trademark Office (USPTO). A patent...

2020-07-08 01:00 1221

Senhwa Biosciences's Silmitasertib Receives Rare Pediatric Disease Designation from U.S. FDA for Treatment of Recurrent Sonic Hedgehog Medulloblastoma

TAIPEI and SAN DIEGO, July 7, 2020 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on Next Generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, today announced that the U.S. Food and Drug Administration (FDA) ...

2020-07-07 21:00 2532

Happiness Biotech Announced Receipt of NPN License in Canada for Its Hand Sanitizer

NANPING, China, July 7, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today that the 75% Alcohol Disposable Hand Sanitizer from the Companyhas successfully obtained Natural P...

2020-07-07 20:00 6091

A Breakthrough in Cancer Treatment: Soundny Presents a New Drug-based Alternative in Fight Against Cancer

WUHAN, China, July 7, 2020 /PRNewswire/ -- Hubei Soundny Biotechnology ("Soundny" or the "Company"), a leading biotechnology company dedicated to developing cancer treatments, has published its latest findings on cholangiocarcinoma in Nature Biomedical Engineering, a Nature publication. The rese...

2020-07-07 18:09 917

Genesis Healthcare Co. launched 'GeneLife Generations', a New Ancestry Kit Designed for the Diversity and Richness of Asian Ethnicities and Ancestral Heritage

SINGAPORE, July 7, 2020 /PRNewswire/ -- Genesis Healthcare Co., Japan's leading genetic testing and research company, today announced the launch of its Asian ancestry focused test kit,GeneLife Generations. The test kit will be officially available to customers from20 July 2020.

2020-07-07 17:32 2202

HULFT and parent company Saison Information Systems to donate 1% of operating income to charity

SINGAPORE, July 7, 2020 /PRNewswire/ -- The impact of COVID-19 has been felt acutely across the world, within workplaces, and among individuals. In response, HULFT, a comprehensive data logistics platform, is proud to announce its first corporate giving program which will be managed through its p...

2020-07-07 14:02 1570
1 ... 660661662663664665666 ... 817